Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design

John Broad; Damien Maurel; Victor W.S. Kung; Gareth A. Hicks; Michael Schemann; Michael R. Barnes; Terrence P. Kenakin; Sébastien Granier; Gareth J. Sanger

doi:10.1038/srep30797

Back

Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design

Journal article

Open access

Peer reviewed

Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design

John Broad, Damien Maurel, Victor W.S. Kung, Gareth A. Hicks, Michael Schemann, Michael R. Barnes, Terrence P. Kenakin, Sébastien Granier and Gareth J. Sanger

Scientific Reports, Vol.6

08/2016

DOI: https://doi.org/10.1038/srep30797

Files and links (2)

url

Find in HALView

url

https://doi.org/10.1038/srep30797View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design
Creators - without role: John Broad - Queen Mary University of London
Damien Maurel - Université de Montpellier, Institut de Génomique Fonctionnelle - IGF
Victor W.S. Kung - Barts & The London School of Medicine and Dentistry [London, UK]
Gareth A. Hicks - Tioga Pharmaceuticals [San Diego, CA, USA]
Michael Schemann - Weihenstephan-Triesdorf University of Applied Sciences
Michael R. Barnes - William Harvey Research Institute
Terrence P. Kenakin - Deparment of Pharmacology [Chapel Hill, NC, USA]
Sébastien Granier - Institut de Génomique Fonctionnelle
Gareth J. Sanger - Queen Mary University of London
Publication Details: Scientific Reports, Vol.6
Identifiers: 9944843009311
Academic Unit: Institut de Génomique Fonctionnelle - IGF
Language: English
Resource Type: Journal article
Local Fields: hal-01940963